OBJECTIVE: The best known neurobehavioral effects of testosterone are on sexual function and aggression. However, testosterone and other androgens may be involved in the pathophysiology of mood disorders and suicidal behavior. This is the first study to examine whether there is a relation between testosterone levels and clinical parameters in bipolar suicide attempters. METHODS: Patients with a DSM-IV diagnosis of a bipolar disorder (16 males and 51 females), in a depressive or mixed episode with at least one past suicide attempt were enrolled. Demographic and clinical parameters, including lifetime suicidal behavior, were assessed and recorded. Plasma testosterone was assayed using a double antibody radioimmunoassay procedure. RESULTS: The number of major depressive episodes, the maximum lethality of suicide attempts, and the testosterone levels were higher in men compared to women. Current suicidal ideation scores were higher in women compared to men. Controlling for sex, we found that testosterone levels positively correlated with the number of manic episodes and the number of suicide attempts. CONCLUSION: Our findings are consistent with previous observations of the association between testosterone levels and parameters of mood and behavior. This study suggests that testosterone levels may be related to the course of bipolar disorder and suicidal behavior. Further studies of the role of testosterone in the neurobiology of mood disorders and suicidal behavior are merited.
OBJECTIVE: The best known neurobehavioral effects of testosterone are on sexual function and aggression. However, testosterone and other androgens may be involved in the pathophysiology of mood disorders and suicidal behavior. This is the first study to examine whether there is a relation between testosterone levels and clinical parameters in bipolar suicide attempters. METHODS:Patients with a DSM-IV diagnosis of a bipolar disorder (16 males and 51 females), in a depressive or mixed episode with at least one past suicide attempt were enrolled. Demographic and clinical parameters, including lifetime suicidal behavior, were assessed and recorded. Plasma testosterone was assayed using a double antibody radioimmunoassay procedure. RESULTS: The number of major depressive episodes, the maximum lethality of suicide attempts, and the testosterone levels were higher in men compared to women. Current suicidal ideation scores were higher in women compared to men. Controlling for sex, we found that testosterone levels positively correlated with the number of manic episodes and the number of suicide attempts. CONCLUSION: Our findings are consistent with previous observations of the association between testosterone levels and parameters of mood and behavior. This study suggests that testosterone levels may be related to the course of bipolar disorder and suicidal behavior. Further studies of the role of testosterone in the neurobiology of mood disorders and suicidal behavior are merited.
Authors: Claudia F Baldassano; Lauren B Marangell; Laszlo Gyulai; S Nassir Ghaemi; Hadine Joffe; Deborah R Kim; Kemal Sagduyu; Christine J Truman; Stephen R Wisniewski; Gary S Sachs; Lee S Cohen Journal: Bipolar Disord Date: 2005-10 Impact factor: 6.744
Authors: Leo Sher; Maria A Oquendo; Hanga C Galfalvy; Michael F Grunebaum; Ainsley K Burke; Gil Zalsman; J John Mann Journal: Addict Behav Date: 2004-12-29 Impact factor: 3.913
Authors: Izabela Kawa; Janet D Carter; Peter R Joyce; Caroline J Doughty; Chris M Frampton; J Elisabeth Wells; Anne E S Walsh; Robin J Olds Journal: Bipolar Disord Date: 2005-04 Impact factor: 6.744
Authors: Marian I Butterfield; Karen M Stechuchak; Kathryn M Connor; Jonathan R T Davidson; Chungsheng Wang; Courteney L MacKuen; Anne M Pearlstein; Christine E Marx Journal: Am J Psychiatry Date: 2005-02 Impact factor: 18.112
Authors: Ayal Schaffer; Erkki T Isometsä; Leonardo Tondo; Doris H Moreno; Mark Sinyor; Lars Vedel Kessing; Gustavo Turecki; Abraham Weizman; Jean-Michel Azorin; Kyooseob Ha; Catherine Reis; Frederick Cassidy; Tina Goldstein; Zoltán Rihmer; Annette Beautrais; Yuan-Hwa Chou; Nancy Diazgranados; Anthony J Levitt; Carlos A Zarate; Lakshmi Yatham Journal: Aust N Z J Psychiatry Date: 2015-07-16 Impact factor: 5.744
Authors: Andrea Gogos; Luke J Ney; Natasha Seymour; Tamsyn E Van Rheenen; Kim L Felmingham Journal: Br J Pharmacol Date: 2019-03-14 Impact factor: 8.739
Authors: Daniel C Mathews; Erica M Richards; Mark J Niciu; Dawn F Ionescu; Joseph J Rasimas; Carlos A Zarate Journal: Transl Neurosci Date: 2013-06 Impact factor: 1.757
Authors: Leo Sher; Michael F Grunebaum; Gregory M Sullivan; Ainsley K Burke; Thomas B Cooper; J John Mann; Maria A Oquendo Journal: J Affect Disord Date: 2014-05-05 Impact factor: 4.839
Authors: Sophia C Gaynor; Eric T Monson; Marie E Gaine; Michael S Chimenti; Rachel D Reichman; Meredith Parsons; Lalita Oonthonpan; Peter P Zandi; James B Potash; Virginia L Willour Journal: J Psychiatr Res Date: 2019-11-18 Impact factor: 4.791